TriNetX Recognized Among Top Healthcare Software Companies for 2025

TriNetX has been named one of the Top 25 Healthcare Software Companies of 2025 by The Healthcare Technology Report, recognizing the company's rapid growth and transformative contributions to life sciences and healthcare. This prestigious award celebrates TriNetX's pioneering software solutions and its position as the operator of the world's broadest federated network of real-world data and evidence.

Steve Kundrot, Chief Operating Officer of TriNetX, stated that this recognition reflects the company's vision of powering innovation across the healthcare ecosystem through data, intelligence, and technology. By combining a global, privacy-compliant network of real-world data with cutting-edge AI and analytics, TriNetX is not only solving current clinical research challenges but also building the foundation for the next generation of precision, representativeness, and speed in drug development.

The company's flagship platform, TriNetX LIVE, integrates de-identified patient data from over 300 million patients across more than 200 healthcare organizations and 8,800 sites worldwide. This globally federated, privacy-compliant network provides clinical trials with deeply enriched datasets including electronic health records, genomics, and claims data. This enables researchers to build precise patient cohorts and conduct real-time, advanced analyses that were previously impossible at this scale.

In 2025, TriNetX continues to push boundaries with next-generation features that simplify workflows, improve collaboration, and make data more intuitive to use. The platform's forthcoming integration of large language models promises to transform how researchers query electronic health records, making access to clinical insights as simple as asking a question. Additional information about The Healthcare Technology Report's Top 25 Healthcare Software Companies of 2025, including the full list of awardees, can be found on their website.

The real-world impact of TriNetX's technology is already evident across multiple dimensions of healthcare research. AI-driven models show promise in improving patient recruitment and enabling earlier detection in diseases like Crohn's, pancreatic cancer, and lupus. Protocol optimization tools have helped reduce costly trial amendments by up to 50%, representing significant cost savings and efficiency improvements for pharmaceutical companies and research institutions.

Digital waiting rooms and site intelligence features are reshaping how and where clinical trials recruit patients, improving representativeness, efficiency, and results. This has profound implications for making clinical research more inclusive and accessible to diverse patient populations. TriNetX's network has supported over 2,000 peer-reviewed publications and is actively shaping clinical practice, regulatory decisions, and global health policy.

For more information about TriNetX and its healthcare data platform, visit www.trinetx.com. The company's recognition as a top healthcare software company underscores the growing importance of data-driven approaches in accelerating medical innovation and improving patient outcomes worldwide.